Method for chemically synthesizing Helicobacter pylori core lipopolysaccharide oligosaccharide antigen carbohydrate chain
US-12018306-B2 · Jun 25, 2024 · US
US12324832B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12324832-B2 |
| Application number | US-202117391061-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 2, 2021 |
| Priority date | Apr 13, 2020 |
| Publication date | Jun 10, 2025 |
| Grant date | Jun 10, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed is the application of heptoglycan-chain-containing oligosaccharide compounds in preparation of a vaccine against Helicobacter pylori , belonging to the field of medicine. Different antigen oligosaccharides were obtained by chemical synthesis and fixed onto a chip surface to prepare a synthetic oligosaccharide chip. With animal immunization experiments and synthetic oligosaccharide chip analysis, the antibodies in antiserum produced by Helicobacter pylori polysaccharide immunization are used to determine the structure-activity relationship between the synthetic oligosaccharides and immunogenicity. It is found that the heptoglycan chain in the oligosaccharide compounds is an important immune epitope, and oligosaccharides containing α-(1→3) heptoglycan chain can be used in preparation and development of vaccines for prevention and treatment of Helicobacter pylori infection.
Opening claim text (preview).
What is claimed is: 1. A method for preparing a vaccine against Helicobacter pylori , comprising the step of incorporating a heptoglycan-chain-containing oligosaccharide of the structure (I) as an active component in the vaccine formulation 2. The method of claim 1 , wherein a synthesis process of the heptoglycan-chain-containing oligosaccharide is as follows: 3. An oligosaccharide chip, wherein the oligosaccharide chip is prepared by fixing the heptoglycan-chain-containing oligosaccharide of claim 1 onto a chip surface through an amino linker of the oligosaccharide. 4. A vaccine for the prevention and treatment of Helicobacter pylori infection, comprising the heptoglycan-chain-containing oligosaccharide of claim 1 as an active component.
Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages · CPC title
Processes for the preparation of sugar derivatives · CPC title
Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter · CPC title
for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants · CPC title
Antibacterial agents · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.